Natixis »

Soleno Therapeutics shares owned by Natixis

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Natixis

Quarter filed Position value Share count Share price at filing
2025-12-31 $641k 14k 46.30

More positions owned by Natixis

Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Spdr Series Trust State Street Spd (SPYM)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Apple (AAPL)
Energy Transfer Com Ut Ltd Ptn (ET)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Equinix (EQIX)
Coinbase Global Com Cl A (COIN)

View all positions for Natixis

Top funds holding Soleno Therapeutics

FMR
Henderson Group
BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
Wellington Management Company
Nantahala Capital Management
Adage Capital Partners GP
Millennium Management
Commodore Capital
Braidwell
Geode Capital Management
Polar Capital Holdings
Woodline Partners

View all funds holding Soleno Therapeutics